New Key Statistics Module, Z-Score and F-Score
NAS:VNDA Key Ratios
Market Cap $ M | 306.70 |
Enterprise Value $ M | -60.47 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.56 |
Price/Sales | 1.74 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 177.00 |
EPS (TTM) $ | -0.08 |
Beneish M-Score | -1.45 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -210.20 |
EV-to-EBIT | 2.33 |
EV-to-EBITDA | 2.85 |
PEG | -- |
Shares Outstanding M | 58.20 |
Net Margin (%) | -2.75 |
Operating Margin % | -14.18 |
Pre-tax Margin (%) | -2.17 |
Quick Ratio | 4.69 |
Current Ratio | 4.71 |
ROA % (ttm) | -0.76 |
ROE % (ttm) | -0.90 |
ROIC % (ttm) | -15.12 |
Dividend Yield % | -- |
Altman Z-Score | 2.34 |
VNDA Number of Guru Trades
VNDA Volume of Guru Trades
Gurus Latest Trades with NAS:VNDA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VNDA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Vanda Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:VNDA
Total 0- 1